BR112014001751A2 - derivados de pirazolina e seu uso como moduladores seletivos do receptor de estrogênio - Google Patents
derivados de pirazolina e seu uso como moduladores seletivos do receptor de estrogênioInfo
- Publication number
- BR112014001751A2 BR112014001751A2 BR112014001751A BR112014001751A BR112014001751A2 BR 112014001751 A2 BR112014001751 A2 BR 112014001751A2 BR 112014001751 A BR112014001751 A BR 112014001751A BR 112014001751 A BR112014001751 A BR 112014001751A BR 112014001751 A2 BR112014001751 A2 BR 112014001751A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrazoline derivatives
- estrogen receptor
- receptor modulators
- selective estrogen
- substituents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
abstract the invention relates to a compound of formula (i) in free form or in pharmaceutically acceptable salt form (i) in which the substituents are as defined in the specification; to its preparation, to its use as a medicament and to medicaments comprising it. the present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition. ------------------------------------------------------------------------------- tradução do resumo resumo patente de invenção: "derivados de pirazolina e seu uso como moduladores seletivos do receptor de estrogênio". trata-se do composto da fórmula (i) sob a forma livre ou sob a forma de sal farmaceuticamente aceitável (i) em que os substituintes são conforme definido no relatório descritivo; de sua preparação, e seu uso como um medicamento e de medicamentos que compreendem o mesmo. a presente invenção proporciona ainda uma com-binação de agentes farmacologicamente ativos e uma composição farmacêutica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2140DE2011 | 2011-07-27 | ||
PCT/IB2012/053795 WO2013014627A1 (en) | 2011-07-27 | 2012-07-25 | Pyrazoline derivatives and their use as selective androgen receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014001751A2 true BR112014001751A2 (pt) | 2017-02-14 |
Family
ID=46845787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014001751A BR112014001751A2 (pt) | 2011-07-27 | 2012-07-25 | derivados de pirazolina e seu uso como moduladores seletivos do receptor de estrogênio |
Country Status (12)
Country | Link |
---|---|
US (1) | US9051326B2 (pt) |
EP (1) | EP2736910B1 (pt) |
JP (1) | JP2014521635A (pt) |
KR (1) | KR20140059202A (pt) |
CN (1) | CN103857678A (pt) |
AU (1) | AU2012288457B2 (pt) |
BR (1) | BR112014001751A2 (pt) |
CA (1) | CA2842566A1 (pt) |
EA (1) | EA023970B1 (pt) |
ES (1) | ES2551923T3 (pt) |
MX (1) | MX2014001086A (pt) |
WO (1) | WO2013014627A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9682960B2 (en) | 2013-12-19 | 2017-06-20 | Endorecherche, Inc. | Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety |
WO2022204235A1 (en) * | 2021-03-23 | 2022-09-29 | Nido Biosciences, Inc. | Bicyclic compounds as androgen receptor modulators |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292742A (en) * | 1993-04-23 | 1994-03-08 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
TW200407324A (en) * | 2002-05-17 | 2004-05-16 | Bristol Myers Squibb Co | Bicyclic modulators of androgen receptor function |
US7405234B2 (en) * | 2002-05-17 | 2008-07-29 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
JP5203712B2 (ja) | 2005-01-10 | 2013-06-05 | アカディア ファーマシューティカルズ インコーポレイテッド | 選択的アンドロゲン受容体モジュレータとしてのアミノフェニル誘導体 |
AU2007212191B2 (en) * | 2006-02-10 | 2011-12-22 | Janssen Pharmaceutica N.V. | Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators |
-
2012
- 2012-07-25 EA EA201490342A patent/EA023970B1/ru not_active IP Right Cessation
- 2012-07-25 ES ES12758894.5T patent/ES2551923T3/es active Active
- 2012-07-25 WO PCT/IB2012/053795 patent/WO2013014627A1/en active Application Filing
- 2012-07-25 CA CA2842566A patent/CA2842566A1/en not_active Abandoned
- 2012-07-25 KR KR1020147004665A patent/KR20140059202A/ko not_active Application Discontinuation
- 2012-07-25 EP EP12758894.5A patent/EP2736910B1/en not_active Not-in-force
- 2012-07-25 MX MX2014001086A patent/MX2014001086A/es not_active Application Discontinuation
- 2012-07-25 CN CN201280045719.6A patent/CN103857678A/zh active Pending
- 2012-07-25 JP JP2014522196A patent/JP2014521635A/ja active Pending
- 2012-07-25 US US14/234,599 patent/US9051326B2/en not_active Expired - Fee Related
- 2012-07-25 AU AU2012288457A patent/AU2012288457B2/en not_active Expired - Fee Related
- 2012-07-25 BR BR112014001751A patent/BR112014001751A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2012288457A1 (en) | 2014-02-13 |
EA201490342A1 (ru) | 2014-06-30 |
CA2842566A1 (en) | 2013-01-31 |
ES2551923T3 (es) | 2015-11-24 |
EP2736910B1 (en) | 2015-08-19 |
JP2014521635A (ja) | 2014-08-28 |
AU2012288457B2 (en) | 2016-03-24 |
EP2736910A1 (en) | 2014-06-04 |
US9051326B2 (en) | 2015-06-09 |
US20140329876A1 (en) | 2014-11-06 |
MX2014001086A (es) | 2014-02-27 |
KR20140059202A (ko) | 2014-05-15 |
EA023970B1 (ru) | 2016-07-29 |
CN103857678A (zh) | 2014-06-11 |
WO2013014627A1 (en) | 2013-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
BR112015029401A8 (pt) | derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas | |
DOP2011000343A (es) | Derivados de piridina tieno [2,3-b] como inhibidores de replicacion viral | |
BR112014015845A2 (pt) | derivados de azetidina, composições farmacêuticas e seu uso | |
BR112015031903A2 (pt) | composto, sal farmaceuticamente aceitável do composto, composição farmacêutica e utilização de um composto | |
BR112015016911A2 (pt) | tiadiazol, análogos dos mesmos e métodos de tratamento de condições relacionadas à deficiência de smn | |
BR112015014372A8 (pt) | inibidores de autotaxina, seus usos, e composição e combinação farmacêuticas". | |
BR112013027670A2 (pt) | "composto de amida, composição farmacêutica e medicamento que o compreende e antagonista de rory" | |
BR112015000578A2 (pt) | moduladores da via do complemento e usos dos mesmos | |
BRPI0821115A8 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
BR112013017779A2 (pt) | derivados de oxazina e seu uso no tratamento de distúrbios neurológicos | |
BR112014018953A8 (pt) | Derivados de lupano triterpenoide e uso farmacêutico dos mesmos | |
GT201400059A (es) | Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, proceidmientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparacion de medicamentos | |
CO6630134A2 (es) | Formulación orales y sales lipofílicas de metilnaltrexona | |
BR112015007647A2 (pt) | derivados de quetamina | |
BR112013026257A2 (pt) | derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes | |
BR112013000059A2 (pt) | derivados de piperidina e seus usos para o tratamento de distúrbios metabólicos | |
BR112015030315A2 (pt) | derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo | |
CO7160008A2 (es) | Derivados de estra- 1,3,5(10),16- tetraeno 3-sustituidos, métodos para su preparación, prepara-ciones farmaceúticas que los contienen, así como su uso para la preparación de medicamentos | |
BR112015022758A2 (pt) | derivados de pirrolidina, composições farmacêuticas contendo os mesmos e seu uso em terapia | |
BR112013026361A2 (pt) | derivados de glicosídeo e usos dos mesmos | |
BR112015001207A8 (pt) | derivados de carbamato/ureia, seus usos, composição farmacêutica, forma livre e seu método de preparação | |
BR112014014795A2 (pt) | sistema de pélete de multiunidade de liberação imediata | |
BR112015014433A2 (pt) | compostos tricíclicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law | ||
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |